Focus Partners Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Focus Partners Wealth's BMY Position: Q1 2026 in Review
Focus Partners Wealth increased its Bristol-Myers Squibb (BMY) stake by 12% in Q1 2026, buying an estimated $3.83M and bringing the position to 624,337 shares worth $37.9M. The position accounts for 0.04% of the portfolio, ranked #348.
Focus Partners Wealth first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Focus Partners Wealth held 624,337 shares of Bristol-Myers Squibb worth $37.9M as of Q1 2026.
- Focus Partners Wealth bought 65,636 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.83M.
- Bristol-Myers Squibb made up 0.04% of Focus Partners Wealth's portfolio in Q1 2026, its #348 holding.
- Focus Partners Wealth first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.